Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Luye Pharma Group Ltd

+ Add to Watchlist

2186:HK

9.400 HKD 0.120 1.29%

As of 04:01:04 ET on 03/26/2015.

Snapshot for Luye Pharma Group Ltd (2186)

Open: 9.280 Day's Range: 9.230 - 9.500 Volume: 5,320,000
Previous Close: 9.280 52wk Range: 6.510 - 11.540 1-Yr Rtn: -

Stock Chart for 2186

No chart data available.
  • 2186:HK 9.400
  • 1D
  • 1M
  • 1Y
9.280
Interactive 2186 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2186

Current P/E Ratio (ttm) 11.9482
Estimated P/E(12/2014) 41.8128
Relative P/E vs. HSI 1.1550
Earnings Per Share (CNY) (ttm) 0.6301
Est. EPS (CNY) (12/2014) 0.1800
Est. PEG Ratio -
Market Cap (M HKD) 31,218.09
Shares Outstanding (M) 3,321.07
30 Day Average Volume 4,070,455
Price/Book (mrq) 2.0964
Price/Sale (ttm) 1.4745
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2186

No data available

Company Profile & Key Executives for 2186

Luye Pharma Group focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.

Liu Dian BoChairman/FounderLiu Yuan ChongChief Financial Officer
Li You XinExec VP:Research & DevelopmentJiang HuaVP/Head:International Business
More Company Profile & Key Executives for 2186

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil